English version of this page

Mor, barn og LAR (GOBLAR)

Omfatter kvinner i LAR som har brukt LAR legemiddel i graviditeten og deres barn

 

Om prosjektet

30-50 kvinner føder årlig barn etter å ha brukt LAR legemidler i svangerskapet. 40-90 % av de nyfødte barna får NAS (neonatalt abstinenssyndrom) etter fødsel. Helsedirektoratet utga nasjonale retningslinjer om gravide i legemiddelassistert rehabilitering (LAR) i 2011 og 2019. Det er fortsatt mange ubesvarte spørsmål knyttet til graviditet, fødsel og barnas og kvinnenes videre forløp psykososialt og kognitivt.

Samarbeidsprosjektet omfatter både prospektive (2005-2007) og retrospektive grupper av mødre og deres barn som har vært undersøkt på flere tidspunkter i barnas liv. Det er levert 4 PhD grader (Sarfi 2012, Lund 2013, Konijnenberg 2013, Welle-Strand 2015) på data fra ulike deler av prosjektet.

Utvalgte publikasjoner

Sarfi, M., Eikemo, M., & Konijnenberg, C. (2022). Children born to women in opioid maintenance treatment: A longitudinal study of child behavioral problems and parenting stress. Frontiers in pediatrics10, 1087956.

Sarfi, M., Eikemo, M., Welle-Strand, G. K., Muller, A. E., & Lehmann, S. (2022). Mental health and use of health care services in opioid-exposed school-aged children compared to foster children. European Child & Adolescent Psychiatry, 1-15.

Welle-Strand, G. K., Skurtveit, S., Abel, K. F., Chalabianloo, F., & Sarfi, M. (2020). Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancy. Journal of Substance Abuse Treatment113, 108004.

Myrvold, T., Christiansen, Ø., Haune, M., Sarfi, M., Heiervang, E.; (2020) Evalueringa av CARE-modellen. Tverrrfaglig kartlegging av utsatte barna helse og omsorgsbehov. Rapport, Institutt for klinisk medisin, Uio, 2020ISBN 978-82-692293-1-8

Eikemo, M., Lobmaier, P. P., Pedersen, M. L., Kunøe, N., Matziorinis, A. M., Leknes, S., & Sarfi, M. (2019). Intact responses to non-drug rewards in long-term opioid maintenance treatment. Neuropsychopharmacology44(8), 1456-1463.

Konijnenberg, C., Sarfi, M., & Melinder, A. (2016). Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine. Early human development101, 91-97.

Welle-Strand, G. K., Skurtveit, S., Tanum, L., Waal, H., Bakstad, B., Bjarkø, L., & Ravndal, E. (2015). Tapering from methadone or buprenorphine during pregnancy: maternal and neonatal outcomes in Norway 1996-2009. European addiction research21(5), 253-261.

Konijnenberg, C., Lund, I. O., & Melinder, A. (2015). Behavioural outcomes of four-year-old children prenatally exposed to methadone or buprenorphine: a test of three risk models. Early Child Development and Care185(10), 1641-1657.

Welle-Strand, G. K., Kvamme, O., Andreassen, A., & Ravndal, E. (2014). A woman's experience of tapering from buprenorphine during pregnancy. Case Reports2014, bcr2014207207.

WelleStrand, G. K., Skurtveit, S., Jansson, L. M., Bakstad, B., Bjarkø, L., & Ravndal, E. (2013). Breastfeeding reduces the need for withdrawal treatment in opioidexposed infants. Acta paediatrica102(11), 1060-1066.

Welle-Strand, G. K., Skurtveit, S., Jones, H. E., Waal, H., Bakstad, B., Bjarkø, L., & Ravndal, E. (2013). Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Drug and alcohol dependence127(1-3), 200-206.

Melinder, A., Konijnenberg, C., & Sarfi, M. (2013). Deviant smooth pursuit in preschool children exposed prenatally to methadone or buprenorphine and tobacco affects integrative visuomotor capabilities. Addiction108(12), 2175-2182.

Sarfi, M., Sundet, J. M., & Waal, H. (2013). Maternal stress and behavioral adaptation in methadone-or buprenorphine-exposed toddlers. Infant Behavior and Development36(4), 707-716.

Lund, I. O., Brendryen, H., & Ravndal, E. (2014). A longitudinal study on substance use and related problems in women in opioid maintenance treatment from pregnancy to four years after giving birth. Substance abuse: research and treatment8, SART-S15055.

Lund, I. O., Skurtveit, S., Engeland, A., Furu, K., Ravndal, E., & Handal, M. (2013). Prescription drug use among pregnant women in opioid maintenance treatment. Addiction108(2), 367-376.

Lund, I. O., Skurtveit, S., Sarfi, M., Bakstad, B., Welle-Strand, G., & Ravndal, E. (2013). A 2-year prospective study of psychological distress among a national cohort of pregnant women in opioid maintenance treatment and their partners. Journal of Substance Use18(2), 148-160.

Lund, I. O., Skurtveit, S., Sarfi, M., Bakstad, B., Welle-Strand, G., & Ravndal, E. (2012). Substance use during and after pregnancy among a national cohort of pregnant women in opioid maintenance treatment and their partners. Journal of Substance use17(3), 277-286.

Bakstad, B., Sarfi, M., Welle-Strand, G. K., & Ravndal, E. (2009). Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome: a national prospective study. European addiction research15(3), 128-134.

Publisert 27. jan. 2012 14:29 - Sist endret 30. jan. 2024 11:17

Kontakt

Prosjektleder

  • Annamaria Monika Sarfi

Deltakere

  • Annamaria Monika Sarfi
  • Gabrielle Welle-Strand
Detaljert oversikt over deltakere